• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肥胖糖尿病(NOD)小鼠对谷氨酸脱羧酶(GAD67)的内源性免疫反应受辅助免疫疗法调节。

Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.

作者信息

Qin H Y, Elliott J F, Lakey J R, Rajotte R V, Singh B

机构信息

Department of Microbiology and Immunology, University of Western Ontario, Canada.

出版信息

J Autoimmun. 1998 Dec;11(6):591-601. doi: 10.1006/jaut.1998.0243.

DOI:10.1006/jaut.1998.0243
PMID:9878081
Abstract

We have shown that immunization of non-obese diabetic (NOD) mice with adjuvants (CFA or BCG) prevents the onset of diabetes by induction of regulatory cells. Since autoimmune responses to glutamic acid decarboxylase (GAD) are up-regulated in insulin-dependent diabetes mellitus (IDDM), in this study GAD67-specific antibody, T cell proliferation and lymphokine production patterns were analysed in the adjuvant-treated mice to characterize the regulatory mechanisms underlying the protection. We used both spontaneous diabetes and syngeneic islet transplantation models in NOD mice. Protection against spontaneous diabetes and prevention of syngeneic islet graft rejection by CFA or BCG treatment was found to be accompanied by the production of long lasting and high titre anti-GAD67 antibody of IgG1 isotype in the sera. Upon in vitro stimulation with GAD67, draining lymph node and spleen cells from CFA-immunized NOD mice or syngeneic islet-grafted and BCG-protected NOD mice produced much more IL-4, whereas there was no significant change in IFN-gamma production. The strong early T cell proliferative response to GAD67 in CFA or BCG-immunized NOD mice was followed by a low or unresponsiveness state. Taken together, these results suggest a shift in Th1/Th2 balance in the GAD67-specific endogenous immune response to a change in Th2 levels after adjuvant treatment. We postulate that the protective effect of CFA or BCG is due to the diversion of GAD-specific endogenous cellular immune response to a non-pathogenic humoral response.

摘要

我们已经表明,用佐剂(完全弗氏佐剂或卡介苗)免疫非肥胖糖尿病(NOD)小鼠可通过诱导调节性细胞来预防糖尿病的发生。由于在胰岛素依赖型糖尿病(IDDM)中,对谷氨酸脱羧酶(GAD)的自身免疫反应上调,因此在本研究中,对经佐剂处理的小鼠分析了GAD67特异性抗体、T细胞增殖和淋巴因子产生模式,以表征保护作用背后的调节机制。我们在NOD小鼠中使用了自发性糖尿病和同基因胰岛移植模型。发现用完全弗氏佐剂或卡介苗处理可预防自发性糖尿病并防止同基因胰岛移植排斥,同时血清中会产生持久且高滴度的IgG1同种型抗GAD67抗体。用GAD67进行体外刺激后,来自经完全弗氏佐剂免疫的NOD小鼠或同基因胰岛移植且经卡介苗保护的NOD小鼠的引流淋巴结和脾细胞产生的白细胞介素-4要多得多,而干扰素-γ的产生没有显著变化。在经完全弗氏佐剂或卡介苗免疫的NOD小鼠中,T细胞对GAD67的早期强烈增殖反应之后是低反应或无反应状态。综上所述,这些结果表明,在佐剂处理后,GAD67特异性内源性免疫反应中的Th1/Th2平衡向Th2水平的变化发生了转变。我们推测,完全弗氏佐剂或卡介苗的保护作用是由于GAD特异性内源性细胞免疫反应转向了非致病性体液反应。

相似文献

1
Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.非肥胖糖尿病(NOD)小鼠对谷氨酸脱羧酶(GAD67)的内源性免疫反应受辅助免疫疗法调节。
J Autoimmun. 1998 Dec;11(6):591-601. doi: 10.1006/jaut.1998.0243.
2
BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.卡介苗接种可预防环磷酰胺加速发病后的非肥胖糖尿病(NOD)小鼠发生胰岛素依赖型糖尿病(IDDM)。
J Autoimmun. 1997 Jun;10(3):271-8. doi: 10.1006/jaut.1997.0136.
3
Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.完全弗氏佐剂诱导的T细胞可预防非肥胖糖尿病小鼠糖尿病的发生及过继转移。
J Immunol. 1993 Mar 1;150(5):2072-80.
4
Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development.IFN-γ 在 CFA 介导的 NOD 小鼠糖尿病发展保护中具有关键作用。
Int Immunol. 2009 Nov;21(11):1291-9. doi: 10.1093/intimm/dxp097. Epub 2009 Sep 24.
5
Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.源自经口服和鼻腔给药处理的非肥胖糖尿病(NOD)小鼠的针对胰岛素和谷氨酸脱羧酶(GAD)肽的调节性Th2型T细胞系可抑制糖尿病。
J Autoimmun. 1999 Jun;12(4):251-8. doi: 10.1006/jaut.1999.0278.
6
Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.通过辅助免疫疗法上调糖尿病NOD小鼠胰腺淋巴结中的CD4+CD25+FOXP3+调节性T细胞。
Transplantation. 2009 Jan 27;87(2):198-206. doi: 10.1097/TP.0b013e3181933261.
7
Immunization of diabetes-prone or non-diabetes-prone mice with GAD65 does not induce diabetes or islet cell pathology.用GAD65对糖尿病易感性或非糖尿病易感性小鼠进行免疫接种,不会诱发糖尿病或胰岛细胞病变。
J Autoimmun. 1998 Aug;11(4):335-41. doi: 10.1006/jaut.1998.0206.
8
T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).非肥胖糖尿病(NOD)小鼠在对谷氨酸脱羧酶(GAD(524 - 543))的应答中会使用具有多种精细特异性的T细胞。
J Autoimmun. 1996 Jun;9(3):365-70. doi: 10.1006/jaut.1996.0049.
9
In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.通过干扰素-γ/肿瘤坏死因子-α诱导非肥胖糖尿病(NOD)小鼠体内致糖尿病T细胞凋亡
Int Immunol. 2004 Dec;16(12):1723-32. doi: 10.1093/intimm/dxh173. Epub 2004 Oct 18.
10
Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice.与非肥胖糖尿病(NOD)小鼠自身免疫反应相关的65 kDa和67 kDa谷氨酸脱羧酶上新型T细胞表位的特征分析
J Autoimmun. 1998 Feb;11(1):83-95. doi: 10.1006/jaut.1997.0178.

引用本文的文献

1
Treatment with incomplete Freund's adjuvant and delays diabetes via an interleukin-17-secretion-independent pathway.用不完全弗氏佐剂治疗可通过一条不依赖白细胞介素-17分泌的途径延缓糖尿病。
Exp Ther Med. 2015 May;9(5):1934-1938. doi: 10.3892/etm.2015.2328. Epub 2015 Mar 3.
2
Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.牛分枝杆菌卡介苗感染可使髓鞘少突胶质细胞糖蛋白自身抗原特异性T细胞的迁移从中枢神经系统转向其他部位,并改善实验性自身免疫性脑脊髓炎。
Clin Diagn Lab Immunol. 2003 Jul;10(4):564-72. doi: 10.1128/cdli.10.4.564-572.2003.
3
Adjuvant immunotherapy is dependent on inducible nitric oxide synthase.
辅助免疫疗法依赖于诱导型一氧化氮合酶。
J Exp Med. 2001 Jun 4;193(11):1261-8. doi: 10.1084/jem.193.11.1261.
4
Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.调节自身免疫性I型糖尿病易感性的免疫机制。
Clin Rev Allergy Immunol. 2000 Dec;19(3):247-64. doi: 10.1385/CRIAI:19:3:247.
5
Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.用I-Ag7四聚体检测谷氨酸脱羧酶激活的T细胞。
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14596-601. doi: 10.1073/pnas.250390997.